http://www.unboundmedicine.com/medline/ebm/research/maravirocUnbound MEDLINE is a service provided by Unbound Medicine, Inc. that includes data and services from the U.S. National Library of Medicine's MEDLINE® and PubMed® databases.en-usUnbound Medicine, Inc.http://www.unboundmedicine.com/medline/ebm/record/19920903/full_citation/Maraviroc_in_the_treatment_of_HIV_infection_Ray N 
Maraviroc in the treatment of HIV infection. [JOURNAL ARTICLE]
Drug Des Devel Ther 2009.:151-161.
Abstract | Full Citationhttp://www.unboundmedicine.com/medline/ebm/record/19920876/full_citation/Pharmacotherapy_of_HIV_1_Infection:_Focus_on_CCR5_Antagonist_Maraviroc_Latinovic O, Kuruppu J, Davis C, et al. 
Pharmacotherapy of HIV-1 Infection: Focus on CCR5 Antagonist Maraviroc. [JOURNAL ARTICLE]
Clin Med Ther 2009.:1497-1510.
Abstract | Full Citationhttp://www.unboundmedicine.com/medline/ebm/record/19916987/full_citation/Maraviroc_and_raltegravir_Dubois EA, Cohen AF 
Maraviroc and raltegravir. [Journal Article]
Br J Clin Pharmacol 2009 Nov; 68(5):651-2.
Full Citation | Publisher Full Text | Find Related Articles http://www.unboundmedicine.com/medline/ebm/record/19907215/full_citation/Is_maraviroc_beneficial_in_paradoxical_progressive_multifocal_leukoencephalopathy_immune_reconstitution_inflammatory_syndrome_managementMartin-Blondel G, Cuzin L, Delobel P, et al. 
Is maraviroc beneficial in paradoxical progressive multifocal leukoencephalopathy-immune reconstitution inflammatory syndrome management? [Letter]
AIDS 2009 Nov 27; 23(18):2545-6.
Full Citation | Publisher Full Text | Find Related Articles http://www.unboundmedicine.com/medline/ebm/record/19855252/full_citation/Cerebrospinal_fluid_maraviroc_concentrations_in_HIV_1_infected_patients_Yilmaz A, Watson V, Else L, et al. 
Cerebrospinal fluid maraviroc concentrations in HIV-1 infected patients. [Journal Article, Research Support, Non-U.S. Gov't]
AIDS 2009 Nov 27; 23(18):2537-40.
Abstract | Full Citation | Publisher Full Text | Find Related Articles http://www.unboundmedicine.com/medline/ebm/record/19851115/full_citation/Pharmacokinetic_Interaction_of_Ritonavir_Boosted_Elvitegravir_and_Maraviroc_Ramanathan S, Abel S, Tweedy S, et al. 
Pharmacokinetic Interaction of Ritonavir-Boosted Elvitegravir and Maraviroc. [JOURNAL ARTICLE]
J Acquir Immune Defic Syndr 2009 Oct 22.
Abstract | Full Citation | Find Related Articles http://www.unboundmedicine.com/medline/ebm/record/19838091/full_citation/[Immunorecovery_after_prolonged_HIV_related_immunosuppression:_opportunities_of_the_new_antiretroviral_classes_]Esposito A, Leti W, Fantauzzi A, et al. 
[Immunorecovery after prolonged HIV-related immunosuppression: opportunities of the new antiretroviral classes.] [JOURNAL ARTICLE]
Infez Med 2009 Sep 1; 17(3):178-183.
Abstract | Full Citation | Find Related Articles http://www.unboundmedicine.com/medline/ebm/record/19834318/full_citation/When_and_how_to_use_maraviroc_in_HIV_infected_patients_Soriano V, Perno CF, Kaiser R, et al. 
When and how to use maraviroc in HIV-infected patients. [Editorial, Research Support, Non-U.S. Gov't]
AIDS 2009 Nov 27; 23(18):2377-85.
Full Citation | Publisher Full Text | Find Related Articles http://www.unboundmedicine.com/medline/ebm/record/19812445/full_citation/Pharmacokinetics_safety_and_tolerability_of_a_single_oral_dose_of_maraviroc_in_HIV_negative_subjects_with_mild_and_moderate_hepatic_impairment_Abel S, Davis JD, Ridgway CE, et al. 
Pharmacokinetics, safety and tolerability of a single oral dose of maraviroc in HIV-negative subjects with mild and moderate hepatic impairment. [Journal Article]
Antivir Ther 2009; 14(6):831-7.
Abstract | Full Citation | Find Related Articles http://www.unboundmedicine.com/medline/ebm/record/19769081/full_citation/[New_antiretroviral_drug_classes_in_HIV_therapy]Lehmann C, Meuer K, Kümmerle T, et al. 
[New antiretroviral drug classes in HIV therapy] [Journal Article]
MMW Fortschr Med 2009 Apr 30; 151(18):64-6.
Full Citation